BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy

Overview of attention for article published in Frontiers in oncology, July 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,609 followers.

BAT6026 , a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer https://t.co/5qzw1f5cWe https://t.co/tisaow8My6

24 Aug 2023

Reply Repost Favourite

New research: BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy: OX40 (CD134), a member of the TNF receptor superfamily, is a widely studied costimulatory immune… #oncology https://t.

08 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.